796072-02-1

Basic information

• Product Name: 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentanoic acid
• Synonyms: 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentanoic acid
• CAS NO: 796072-02-1
• Molecular Weight: 535.64
• Mol File: 796072-02-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentanoic acid(796072-02-1)
• EPA Substance Registry System: 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentanoic acid(796072-02-1)

Safety Data

• Hazardous Substances Data: 796072-02-1(Hazardous Substances Data)

Upstream product

• 106928-50-1 methyl 2-[(tert-butoxycarbonyl)amino]pent-4-enoate 
• 119479-32-2 2-((tert-butyloxycarbonyl)amino)-4-pentenoic acid 
• 6999-03-7 1-bromo-4-(trimethylsilyl)benzene 
• 24424-99-5 di-tert-butyl dicarbonate 
• 100124-06-9 4-dibenzofurylboronic acid 
• 796072-30-5 5-(4-bromophenyl)-2-tert-butoxycarbonylamino-4-pentenoic acid methyl ester 
• 796071-96-0 (4-(dibenzo[b,d]furan-4-yl)phenyl)boronic acid 
• 796072-24-7 (4-dibenzofuran-4-yl-phenyl)-trimethyl-silane 
• 796072-31-6 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentenoic acid methyl ester 
• 796072-32-7 2-tert-butoxycarbonylamino-5-(4'-dibenzofuran-4-yl-biphen-4-yl)-5-pentanoic acid methyl ester 

Relevant articles and documents

SUBSTITUTED AMINO CARBOXYLIC ACIDS

Disclosed are compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.